-
1
The Clinical and Public Health Utility of Mutual Aid Organizations in Addressing
Addiction: What Does the Science Tell Us?
John Kelly, PhD, ABPPElizabeth R. Spallin Associate Professor of Psychiatry in
Addiction Medicine, Harvard Medical SchoolTuesday, April 23, 2019
-
2
American Academy of Family Physicians American Psychiatric Association
American Academy of Neurology American Society of Addiction MedicineAddiction Technology Transfer Center American Society of Pain Management
NursingAmerican Academy of Pain Medicine Association for Medical Education and
Research in Substance AbuseAmerican Academy of Pediatrics International Nurses Society on AddictionsAmerican College of Emergency Physicians American Psychiatric Nurses AssociationAmerican College of Physicians National Association of Community Health
CentersAmerican Dental Association National Association of Drug Court
ProfessionalsAmerican Medical Association Southeastern Consortium for Substance
Abuse TrainingAmerican Osteopathic Academy of Addiction Medicine
PCSS is a collaborative effort led by the American Academy of Addiction Psychiatry (AAAP) in partnership with:
-
3
Webinar Housekeeping
Minimize or maximize the webinar panel by selecting the orange arrow.
To be recognized, type your question in the “Question” box and select send.
-
4
Disclosures
• I have no disclosures to report.
-
5
Educational Objectives
• Participants will: Describe the state of the evidence on the efficacy of
mutual-aid for enhancing clinical outcomes for opioid and other substance use disorders.
Detail the magnitude of the potential health care cost savings that can be derived from prescribing and facilitating mutual-aid participation in treatment settings.
List three major mechanisms through which mutual-aid organizations confer therapeutic benefit.
-
6
1970: Public Enemy No. 1
During the past 50 years since “War on Drugs” declared, we have moved from “Public Enemy No. 1” to “Public Health Problem No. 1”
-
7
War on Drugs
• The “war on drugs” was part of a national concerted effort to reduce “supply” but also “demand” that created treatment and public health oriented federal agencies.
-
8
Paradigm Shifts
-
9
Multiple Pathways to Recovery
• Acknowledges myriad ways in which individuals can recover: Clinical pathways: provided
by a clinician or other medical professional – both medication and psychosocial interventions
Non-clinical pathways:services not involving clinicians like AA
Self-management pathways:recovery change processes that involve no formal services, sometimes referred to as “natural recovery”
-
10
“Quitting smoking is easy, I’ve done it dozens of times.”
– Mark Twain
-
11
What people really need is a good listening to…
-
12
Swift, certain, modest, consequences shape behavioral choices…
-
13
-
14
-
15
The clinical course of addiction and achievement of stable recovery can take a long time…
Addiction Onset
Help Seeking
Full Sustained Remission
(1 year abstinent)
Relapse Risk Drops Below 15%
4-5 years 8 years 5 years
Self-initiated Cessation Attempts
4-5 Treatment Episodes/
Mutual-Help
Continuing Care/
Mutual-Help
Recovery Priming
Recovery Monitoring
Recovery Mentoring
50-60% of individuals
with addiction will achieve full sustained remission
www.mghcme.org
-
16
Cadre of emerging and growing long-term Recovery Support Services now exist…
Recovery
Mutual help organizations
Peer-based recovery support services
Sober living environments
Clinical models of long-term recovery
management
Recovery community
centers
Recovery supports in educational
settings(sober dorms)
-
17
Treatment and Recovery Support Services ideally should be…
• Available• Accessible• Affordable• Attractive• Evidence-based• Diverse
-
18
Cadre of emerging and growing long-term Recovery Support Services now exist…
Recovery
Mutual help organizations
Peer-based recovery support services
Sober living environments
Clinical models of long-term recovery
management
Recovery community
centers
Recovery supports in educational
settings(sober dorms)
-
19
Potential Advantages of Community Mutual-Help
Cost-effective –free; attend as intensively, as
long as desired
Focused on addiction
recovery over the long haul
Widely available, easily accessible,
flexible
Access to fellowship/broad support network
Entry threshold (no paperwork, insurance);
anonymous (stigma)
Adaptive community based system that is
responsive to undulating relapse risk
-
20
Recovery Supportive Role Modeling and Influence
-
21
Paradox in Onset and Offset of Substance Use…
• Four main reasons why people starttaking drugs: To feel good To feel better To do better Because other people are doing it
-
22
Paradox in Onset and Offset of Substance Use…
• Four main reasons why people stoptaking drugs: To feel good To feel better To do better Because other people are (not) doing it
-
23
Overarching Principles Possibly at Play Within and Across AA/MHOs
Universality
Instillation of Hope
Catharsis
Cohesion
Imparting of Information
Altruism
Imitative Behavior
Socialization Techniques
Existential Factors
Interpersonal Learning
Self-Understanding/insight
Source: Yalom, 1995
-
24
Recovery-Focused Mutual-Help Groups
Source: Kelly & Yeterian, 2013
Name Year of Origin Number of groups in U.S. Location of groups in U.SEvidence base*
(0-3)
Alcoholics Anonymous (AA) 1935 52,651 all 50 States 1, 2, 3
Narcotics Anonymous (NA) 1940s Approx. 15,000 all 50 States 1, 2
Cocaine Anonymous (CA) 1982 Approx. 2000 groupsmost States; 6 online meetings at
www.ca-online.org 0
Methadone Anonymous (MA) 1990s Approx. 100 groups
25 States; online meetings at http://methadone-anonymous.org/chat.html 1, 2
Marijuana Anonymous (MA) 1989 Approx. 200 groups
24 States; online meetings at www.ma-online.org 0
Rational Recovery (RR) 1988
No group meetings or mutual helping; emphasis is on individual control and
responsibility
----------------------------------------------------- 1, 2
Self-Management and Recovery Training
(S.M.A.R.T. Recovery) 1994Approx. 1100 groups
40 States; online meetings at www.smartrecovery.org/meetings/olschedule.ht
m1, 3
Secular Organization for Sobriety, a.k.a. Save
Ourselves (SOS) 1986Approx. 480 groups all 50 States; Online chat at www.sossobriety.org/sos/chat.htm 1
Women for Sobriety (WFS) 1976 150-300 groupsOnline meetings at
http://groups.msn.com/ WomenforSobriety 1
Moderation Management (MM) 1994
Approx.16 face-to-face meetings
12 States; Most meetings are online at www.angelfire.com/trek/mmchat/; 1
*0= None 1=Descriptive studies only 2 = Observational (correlational, longitudinal) 3= Experimental (random assignment, controlled).
http://www.ca-online.org/http://methadone-anonymous.org/chat.htmlhttp://www.ma-online.org/http://www.smartrecovery.org/meetings/olschedule.htmhttp://www.sossobriety.org/sos/chat.htmhttp://groups.msn.com/%20WomenforSobrietyhttp://www.angelfire.com/trek/mmchat/
-
25
Table 2. Dual-Diagnosis Focused Mutual-Help Groups
Source: Kelly & Yeterian, 2008
Name Year of Origin Number of groups in U.S. Location of groups in U.S.
Double Trouble in Recovery (DTR) 1989 200
Highest number of groups in NY, GA, CA, CO, NM, FL
Dual Recovery Anonymous
(DRA)1989 345 Highest number of groups in CA, OH, PA, MA
Dual Disorders Anonymous 1982 48 28 in IL
Dual Diagnosis Anonymous (DDA) 56 38 in CA
-
26
Table 3. Non-Substance Focused Addictive Behavior Mutual-Help Groups
Source: Kelly & Yeterian, 2013
Name Year of OriginNumber of groups in
U.S. Location of groups in U.S.
Gamblers Anonymous
(GA)1957 Approx. 1000 chapters all 50 States
Sex Addicts Anonymous
(SAA)1977 Approx. 700 meetings
most States; Online meetings at www.sexaa.org/online.htm; Telephone
meetings
Sex and Love Addicts
Anonymous (SLAA)
1976 Approx. 1320 groups worldwide
(including in all 50 States), Online meetings at
www.slaafws.org/online/onlinemeet.html; Regional teleconference calls
Overeaters Anonymous
(OA)1960 Approx. thousands of meetings
all 50 States; Numerous online (www.oa.org/pdf/OnlineMeetingsList.p
df) and telephone meetings (www.oa.org/pdf/phone_mtgs.pdf)
http://www.sexaa.org/online.htmhttp://www.slaafws.org/online/onlinemeet.htmlhttp://www.oa.org/pdf/OnlineMeetingsList.pdfhttp://www.oa.org/pdf/phone_mtgs.pdf
-
27
-
28
TSF Delivery ModesTSFOTH
In past 25 years, AA research has gone from contemporaneous correlational research to
rigorous RCTs, quasi-experiments, cost utility, and MOBC research…
Stand alone independent therapy
Integrated into an existing therapy
Component of a treatment package (e.g. an additional group)
As Modular appendage linkage component
-
29
(9-mo) Self-efficacyNegative Affect
Baseline (BL) CovariatesAgeRaceSexMarital StatusEmployment Status
Prior Alcohol TreatmentMATCH Treatment groupMATCH study site
Alcohol Outcomes (PDA/DDD)
(15-mo) Alcohol Outcomes(PDA or DDD)(3-mo) AA attendance
(BL) Self-efficacyNegative Affect
(9-mo) Self-efficacyPositive Social
(BL) Self-efficacyPositive Social
(9-mo) Religious/SpiritualPractices
(BL) Religious/SpiritualPractices
(9-mo) Depression(BL) Depression
(9-mo) Social Network“pro-abstinence”
(BL) Social Network“pro-abstinence”
(9-mo) Social Networkpro-drinking”
(BL) Social Network“pro-drinking”
… and lagged moderate multiple mediation studies to elucidate its
impact and MOBCs.
-
30
-
31
Facilitation by Dropout-Risk Interaction
Source: Kelly & Moos (2003) Dropout from 12-Step Groups: Prevalence, Predictors and Counteracting Treatment Influences, Journal of Substance Abuse Treatment,24, 241-250
• 40% 12-step dropout rate at 1 year
• Those dropping out had 3x higher odds of relapse
• Those at highest dropout risk treated in 12-step programs had substantially lower dropout than those treated in CBT programs
Chart1
Lo RiskLo Risk
Hi RiskHi Risk
Lo Support
Hi Support
Risk Level
Percent Dropped Out
37
34
57
44
Sheet1
Dichotomized risk level * Dropout or not 1yr * TXMILEU Crosstabulation
Dropout or not 1yrTotal
TXMILEUStill AttendingDropout
Low 12-step support tx milieuDichotomized risk level0Count6513821033
% within Dichotomized risk level63.020329138436.9796708616100
% of Total44.255608429625.968728755970.2243371856
1Count188250438
% within Dichotomized risk level42.922374429257.0776255708100
% of Total12.78042148216.995241332429.7756628144
TotalCount8396321471
% within Dichotomized risk level57.036029911642.9639700884100
% of Total57.036029911642.9639700884100
Hi 12-step tx milieuDichotomized risk level0Count573297870
% within Dichotomized risk level65.862068965534.1379310345100
% of Total55.043227665728.53025936683.5734870317
1Count9675171
% within Dichotomized risk level56.140350877243.8596491228100
% of Total9.22190201737.20461095116.4265129683
TotalCount6693721041
% within Dichotomized risk level64.26512968335.734870317100
% of Total64.26512968335.734870317100
Lo RiskHi Risk
Lo Support3757
Hi Support3444
Sheet1
Lo Support
Hi Support
Risk Level
Percent Dropped Out
Sheet2
Sheet3
-
32
Cochrane Systematic Review on AA/TSF
- Kelly, JF- Humphreys, K- Ferri, M(In progress)
-
33
Alcohol-related Consequences
Alcohol Use Severity
Proportion Completely Abstinent
Percent Days Abstinent
Longest Period of Abstinence
Drinks Per Drinking Day
Percentage of Days Heavy Drinking
Alcohol-related Consequences
Alcohol Use Severity
Brown 2002
Davis 2002
Kelly 2017
Litt 2007
Litt 2009
Litt 2016
Lydecker 2010
MATCH 1997a1 2
MATCH 1998a1
MATCH 1998b1
McCrady 1996
McCrady 1999
McCrady 2004
Walitzer 20093
Walitzer 2015
Blondell 2011
Bogunshutz 2014
Bowen 2014
Kahler 2004
Timko 2006
Timko 2007
Vederhus 2014
Walitzer 20093
Manning 2012
Brooks 2003
Blondell 2001
Humphreys 1996
Humphreys 2001
Humphreys 2007
Ouimette 19973
Timko 2011
Grant 2017
Kaskutas 2009 (6m)
Kaskutas 2009 (12m)
Ouimette 19973
RCTs: All Study Treatment Conditions Manualized, TSF v. TSF Variants
STUDY
Abstinence Drinking Intensity
RCTs: All Study Treatment Conditions Manualized, TSF V. Other Clinical Interventions
RCTs: 1+ Study Treatment Conditions Non-Manualized, TSF v. Other Clinical Interventions
2 At 9m follow-up but equivalent at 15m follow-up for consequences
3 Study compares TSF to another clinical intervention and a TSF variant
RCTs: 1+ Study Treatment Conditions Non-Manualized, TSF v. TSF Variants
Quasi-experimental: All Study Conditions Manualized, TSF v. Other Clinical Interventions
Quasi-experimental: 1+ Study Conditions Non-Manualized, TSF v. Other Clinical Interventions
Quasi-experimental: 1+ Study Conditions Non-Manualized, TSF v. Other Clinical Interventions
Quasi-experimental: 1+ Study Conditions Non-Manualized, TSF v. TSF Variants
1 For outpatients only on DDD
26 original RCTs/Quasi-experimental studies, reporting main findings across 35 publications.
Beneficial effects of TSF interventions observed across several outcomes – particularly sustained remission/abstinence
Reduces health care costs substantially while improving alcohol outcomes
Estimates of beneficial effects are conservative as many in comparison conditions also attending AA despite not being facilitated to do so.
-
34
-
35
-
36
Economic Studies
Healthcare Cost Savings
• Economic analyses found benefits in favor of AA/TSF relative to outpatient treatment, and CBT interventions.
• Magnitude quite large. In addition to sig. increased abstinence compared to CBT interventions, AA/TSF reduces mental health and substance use-related healthcare costs over the next two years by over $10,000 per patient (converted to 2018 U.S. dollars).
• More than 1M people treated for AUD in U.S. annually -reducing their health care costs by this amount would produce an large aggregate economic saving (e.g., >$10 billion in the U.S. alone) as well as improving clinical outcomes.
-
37
AA/TSF Findings Summary
For alcohol-related outcomes other than complete abstinence, AA and professionally-delivered TSF interventions are at least as effective as other well-established treatments.
For abstinence outcomes, AA and TSF interventions are superior to other well-established treatments.
Implementing AA and TSF also appear to produce substantial health care cost savings.
Mediational analyses demonstrate clinically delivered TSF produces its benefits largely through its ability to foster increased AA participation during and, importantly, following the end of formal treatment.
-
38
In studies conducting and reporting mediational analyses…AA/TSF Causal chain supported…
TSF AA BETTER OUTCOME
-
39
What about support for causal chain of purported MOBC of AA on outcomes?
TSF AA BETTER OUTCOME
MOBC?
-
40
Empirically-supported MOBCs through which AA confers benefit
Negative Affect Abstinence self-
efficacy
Social network
Spirituality
Social Abstinence self-efficacy
Recovery motivation
Impulsivity
Craving
Coping skills
-
41
The results of this review suggest that 12-step interventions to support illicit drug users are
as effective as alternative psychosocial interventions in reducing drug use.
-
42
Examining the Efficacy of 4 Psychosocial Treatments for Cocaine-Dependent Patients
• Sample: 487 individuals aged 18 to 60 with DSM-IV cocaine dependence from 5 sites:
• University of Pittsburg (PA)• University of Pennsylvania (PA)• Brookside Hospital (NH)• Massachusetts General Hospital (MA)• McLean Hospital (MA)
• Design: Randomized controlled trial
• Follow-up: Monthly assessments during 6 months of active treatment and follow-up at 9 and 12 months
• Interventions: 4 manual-guided treatments• IDC: Individual drug counseling plus group drug
counseling (GDC); n = 121• CT: Cognitive therapy plus GDC; n = 119• SE: Supportive-expressive therapy plus GDC; n =
124• GDC alone; n = 123
• Outcomes: Addiction Severity Index-Drug Use Composite score, number of days of cocaine use in past month
-
43
Mean ASI-Drug Use Composite Scores
IDC showed significantly better improvement to
ASI than the three other groups
-
44
Continuous Abstinence from Cocaine Use
IDC showed significantly better improvement
compared to CT and SE
By 12 months, IDC increases slightly while
other three groups decline
-
45
Cocaine Use in Past 30 Days
01020304050607080
1 Month 2 Months 3 Months
Per
cent
Months of Continuous Abstinence
IDCCTSEGDC
More patients achieved abstinence with IDC compared to the three other groups
-
46
-
47
Stimulant Abusers to Engage in 12-Step
• Aims: to evaluate the efficacy of an 8-week combined group and individual 12-step facilitative intervention on stimulant drug use and 12-step meeting attendance and service
• Study Design: Multisite, randomized controlled trial• Sample: 471 individuals from intensive outpatient treatment
programs with stimulant use disorders• Measures: Urinalysis and self-reported substance use; 12-step
attendance and activities• Intervention: Control group: Treatment as usual Intervention group (STAGE-12): Group sessions focused on
increasing acceptance of 12-step principles and individual sessions that incorporated an intensive referral procedure connecting participants to 12-step volunteers
-
48
Stimulant Abusers to Engage in 12-Step (STAGE-12)
Odds of Abstinence
Last follow-up (180-day)
Third follow-up (150-day)
Second follow-up (120-day)
First follow-up (90-day)
End-of-treatment (60-day)
Mid-treatment (30-day)
Odds Ratio (OR)0.0 1.0 2.0 3.0
4.0
3.34*
2.44*
1.78
1.30
0.95
0.69
Comparison Group: TAU
-
49
-
50
Abstinence rates higher across all three primary substances at 1yr follow-up for MHO attendees; also at 2 and 5yrs for alcohol and opiates
Abstinence rates higher for alcohol and opiates at 5 year follow-up for participants attending at least weekly MHO meetings
-
51
Outcomes of Buprenorphine and 12-Step Attendance
SAMPLEQuantitative: n=300, (Qualitative: n=20), opioid dependent African Americans newly admitted to buprenorphine maintenance treatment program (BMT)
DESIGNLongitudinal, naturalistic study of 12-step participation among individuals receiving BMT as part of a randomized trial
RELATIONSHIP BETWEEN: 12-Step group attendance & treatment outcomes at 6 months
OUTCOMES(QUALITATIVE) Lack of disclosure of BMT status to NA members, disclosure lead to counsel to stop or decrease BMT treatment,
(QUANTITATIVE) meeting attendance higher in abstinent individuals or those enrolled in BMT, overall, 2% increase in BMT treatment retention for each meeting attended & 1% increase in odds of remaining abstinent
-
52
Buprenorphine Treatment and 12-Step Attendance
Source: Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O’Grady KE, Jaffe JH. Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes. J Subst Abuse Treat 2015; 57: 89-95.
Number of NA meetings prior to 6 months a significant predictor
of treatment retention
Number of NA meetings prior to 6 months a significant predictor
of abstinence
-
53
Effective Clinically Delivered Mutual-Help Strategies Likely to Enhance Outcomes and
Reduce Health Care Costs
• Actively prescribe participation rather than leaving to patient
• Clinically facilitate linkage to existing members• Clinically monitor participation in outpatient sessions• Ask patients to keep diary of experiences for clinical
discussion - help overcome barriers• Encourage acquiring 12-step sponsor, find “home
group”, verbally participate during meetings
-
54
Specific Clinical Strategies for Facilitating Mutual-Aid Participation
• Treatment varied between 3 conditions in terms of how the therapist discussed AA and how much information about AA was shared 1: Directive approach
− Therapist directed − Client signed contract describing goals to attend AA meetings− Therapist encouraged client to keep a journal about meetings− Reading material about AA provided to client− Therapist informs client about skills to use during meetings and sponsor− 38% total material covered in sessions was about AA
2: Motivational enhancement approach (more client centered)− Therapist obtains clients feelings and attitudes about AA− Therapist describes positive aspects of AA, but up to client how much involved− Therapist intends to assist the client in making a decision in favor of AA− 20% total material covered in sessions about AA
3: CBT treatment as usual, no special emphasis on AA− Throughout treatment, therapist briefly inquires about AA and encourages
client to attend AA− 8% total material covered in sessions about AA
Walitzer, Dermen & Barrick, 2009
-
55
Strategies for Facilitating Outpatient Attendance of AA- Findings
• Participants exposed to the Directive TSF approach reported significantly more: attendance of AA meetings more active involvement in AA higher percent days abstinent in comparison to
the treatment as usual group• AA involvement partially mediated effects
-
56
Who’s better at getting patients engaged in Mutual-aid Organizations: Doctors or Peers?
-
57
Active referral to 12-step groups
• Study Design: Randomized controlled trial with 2-3m follow-up
• Sample: 151 alcohol or drug (opiate, cocaine, benzo) dependent patients admitted for a 10-14 day NHS inpatient drug/alcohol detoxification treatment at the Maudsley in London
• Intervention: Control group:
− No-referral intervention (NI): Patient provided with a list of meetings Intervention groups:
− Doctor-referral intervention (DI): initiate a dialogue with patient regarding 12-step meetings
− Peer-referral intervention (PI): initiate a dialogue with patient regarding 12-step meetings and share personal experiences with 12-step groups
-
58
• Active linkages (Peer [PI] or doctor [DI]) produced higher attendance rates than no intervention (NI) (88% vs 73%; p < .05); although NI was still high
• Those attending during tx sig more likely to attend post-tx (59% versus 20%; (2 = 9.9, p < .01).
• Sig group differences in post-discharge attendance rates (PI = 64%, DI = 48%, NI = 33% p < .05)
• Among those without prior 12-Step experience, 33% of PI, 73% of DI, and 0% of NI, group, attended meetings post-tx (p < .01).
Active referral to 12-step groups (Manning et a, 2012)
-
59
“Warm hand-off” Clinician Referrals to AA (Timko et al 2006; 2007)
Individuals entering SUD outpatient program randomly assigned to…
Condition 1: standard referralPatients given locations and schedules of meetings and encouraged to
attend
Condition 2: intensive referralPatients given locations and schedules of meetings, with meetings preferred
by previous clients indicated
Therapist reviews handout about program including introduction to 12-step philosophy and common concerns
Therapist arranged meeting with current member and client had phone conversation with this member during session
Therapist and client agreed on which meetings client will attend and client kept a journal of meetings attended and experiences
-
60
Effectiveness of Clinician Referrals to AA-Findings
• At 6m, patients in intensive referral who had relatively less previous 12-Step experience had:
higher meeting attendance better substance use outcomes
• At both the 6 and 12 month follow up, patients in intensive referral:
more likely to attend at least one meeting per week had higher rates of attendance and had higher rates of
abstinence
-
61
12 Step Alternatives: Main Findings
Smart Recovery
One study found no difference between SR meetings only and SR meetings + an online SR intervention[23]
Peer Alternatives Comparative Efficacy Study
• Adults with AUD who were members of WFS, LifeRing, SMART, or 12-step[24]
• Overall, primary group affiliation and involvement did not predict substance use outcomes over the 1-year period
• SMART Recovery and LifeRing members were less likely than 12-step members to be abstinent at 1-year follow-up; however, these effects were negated when controlling for baseline abstinence goal
Alternatives to 12-step are likely to be as helpful as 12-step involvement at helping
people manage SUDs. However, more research is
needed on alternatives to 12-step, including research on facilitation to these groups.
-
62
Effective Clinically Delivered Mutual-Help Strategies Likely to Enhance Outcomes and
Reduce Health Care Costs
• Actively prescribe participation rather than leaving to patient
• Clinically facilitate linkage to existing members• Clinically monitor participation in outpatient sessions• Ask patients to keep diary of experiences for clinical
discussion - help overcome barriers• Encourage acquiring 12-step sponsor, find “home
group”, verbally participate during meetings
-
63
References
• Emrick, C. D., Tonigan, J. S., Montgomery, H., & Little, L. (1993). Alcoholics Anonymous: What is currently known? In B. S. McCrady & W. R. Miller (Eds.). Research on Alcoholics Anonymous: Opportunities and Alternatives (pp. 41-76). Piscataway, NJ: Rutgers Center of Alcohol Studies.
• Kelly JF. Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction 2017; 112(6):929-936.
• Kelly, J. F., & Moos, R. H. (2003). Dropout from 12-step self-help groups: Prevalence, predictors and counteracting treatment influences. Journal of Substance Abuse Treatment, 24(3), 241-250.
• Kelly, J. F., Stout, R., Zywiak, W. & Schneider, R. (2006). A 3-year study of addiction mutual-help group participation following intensive outpatient treatment. Alcoholism: Clinical and Experimental Research, 30(8), 1381-1392.
• Kelly JF, Magill M, Stout RL. How do people recover from alcohol dependence? A systematic review of the research on mechanisms of behavior change in Alcoholics Anonymous. Addict Res Theory 2009; 17(3):236-259.
• Humphreys, K., & Moos, R. H. (2001). Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study. Alcoholism: Clinical and Experimental Research, 25(5), 711-716.
• Humphreys, K., & Moos, R. H. (2007). Encouraging post-treatment self-help group involvement to reduce demand for continuing care services: Two-year clinical and utilization outcomes. Alcoholism: Clinical and Experimental Research, 31(1), 64-68.
• Yalom, I. D., & Leszcz, M. (2005). The Theory and Practice of Group Psychotherapy (5th ed.). New York: Basic Books.
-
64
PCSS Mentoring Program
• PCSS Mentor Program is designed to offer general information to clinicians about evidence-based clinical practices in prescribing medications for opioid addiction.
• PCSS Mentors are a national network of providers with expertise in addictions, pain, evidence-based treatment including medication-assisted treatment.
• 3-tiered approach allows every mentor/mentee relationship to be unique and catered to the specific needs of the mentee.
• No cost. For more information visit:
https://pcssNOW.org/mentoring/
https://pcssnow.org/mentoring/
-
65
PCSS Discussion Forum
Have a clinical question?
http://pcss.invisionzone.com/register
http://pcss.invisionzone.com/registerhttp://pcss.invisionzone.com/register
-
Opioid Response Network (STR-TA)
Opioid Use Disorder Virtual Learning Collaborative (VLC)– Play a role in expanding the availability of medical for addiction
treatment options for opioid use disorders– Each collaborative runs for 12-weeks and is lead by an
experienced faculty advisor– Participants watch pre-recorded webinars, call into office-hours,
engage with a virtual community and complete an individual project
– Participants will earn up to 12 Continuing Medical Education (CME) credits
– Fill out our interest intake form at apapsy.ch/OpioidSTR Contact Eunice Maize at [email protected] for more information.
66
Funding for this initiative was made possible (in part) by grant no. 6H79TI080816-02 from SAMHSA. The viewsexpressed in written conference materials or publications and by speakers and moderators do not necessarilyreflect the official policies of the Department of Health and Human Services; nor does mention of trade names,commercial practices, or organizations imply endorsement by the U.S. Government.
https://forms.office.com/Pages/ResponsePage.aspx?id=CkUW97KyiUmxDJF-JA-9yC_bp0VkEO9Pg5rRnRIv42JUOEY1T1AyVEwyUkVEVTZHTllNRFRUT1UxMiQlQCN0PWcumailto:[email protected]
-
67
Session Evaluation and Certificate
• Instructions will be provided in an email sent to participants an hour after the live session
• Certificates are available to those who complete an evaluation
• Recordings of today’s webinar can be accessed at www.pcssNOW.org and education.psychiatry.org
http://www.pcssnow.org/
-
68
Upcoming PCSS Webinar
Vaccines for Opioid Use Disorder: Focusing on the Fentanyl Epidemic
Thomas R. Kosten, MDWaggoner Professor in Psychiatry, Pharmacology and
NeuroscienceBaylor College of Medicine
Fang Yang, MD, PhDAddiction Psychiatry FellowBaylor College of Medicine
Tuesday, May 28, 201912:00-1:00 PM EST
-
69
Educate. Train. Mentor
www.pcssNOW.org
@PCSSProjects
www.facebook.com/pcssprojects/
Funding for this initiative was made possible (in part) by grant no. 5U79TI026556-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
http://www.pcssnow.org/mailto:[email protected]://www.twitter.com/PCSSProjectshttps://twitter.com/PCSSprojectshttp://www.facebook.com/pcssprojects/
The Clinical and Public Health Utility of Mutual Aid Organizations in Addressing Addiction: What Does the Science Tell Us?Slide Number 2Webinar HousekeepingDisclosuresEducational Objectives1970: Public Enemy No. 1War on DrugsParadigm ShiftsMultiple Pathways to RecoverySlide Number 10What people really need is a good listening to…Slide Number 12Slide Number 13Slide Number 14 The clinical course of addiction and achievement of stable recovery can take a long time…Cadre of emerging and growing long-term Recovery Support Services now exist…Treatment and Recovery Support Services ideally should be… Cadre of emerging and growing long-term Recovery Support Services now exist…Potential Advantages of Community Mutual-HelpRecovery Supportive Role Modeling and InfluenceParadox in Onset and Offset of Substance Use…Paradox in Onset and Offset of Substance Use…Overarching Principles Possibly at Play Within and Across AA/MHOsRecovery-Focused Mutual-Help Groups Table 2. Dual-Diagnosis Focused Mutual-Help Groups Table 3. Non-Substance Focused Addictive Behavior Mutual-Help Groups Slide Number 27TSF Delivery ModesSlide Number 29Slide Number 30Facilitation by Dropout-Risk InteractionCochrane Systematic Review on AA/TSF��- Kelly, JF�- Humphreys, K�- Ferri, M�(In progress)�Slide Number 33Slide Number 34Slide Number 35Economic StudiesAA/TSF Findings SummaryIn studies conducting and reporting mediational analyses…AA/TSF Causal chain supported…What about support for causal chain of purported MOBC of AA on outcomes?Empirically-supported MOBCs through which AA confers benefitSlide Number 41Examining the Efficacy of 4 Psychosocial Treatments for Cocaine-Dependent PatientsMean ASI-Drug Use Composite ScoresContinuous Abstinence from Cocaine UseCocaine Use in Past 30 DaysSlide Number 46Stimulant Abusers to Engage in 12-StepStimulant Abusers to Engage in 12-Step (STAGE-12)Slide Number 49Slide Number 50Outcomes of Buprenorphine and 12-Step AttendanceBuprenorphine Treatment and 12-Step AttendanceEffective Clinically Delivered Mutual-Help Strategies Likely to Enhance Outcomes and Reduce Health Care CostsSpecific Clinical Strategies for Facilitating Mutual-Aid ParticipationStrategies for Facilitating Outpatient Attendance of AA- FindingsSlide Number 56Active referral to 12-step groupsActive referral to 12-step groups (Manning et a, 2012)“Warm hand-off” �Clinician Referrals to AA (Timko et al 2006; 2007)Effectiveness of Clinician Referrals to AA- Findings12 Step Alternatives: Main FindingsEffective Clinically Delivered Mutual-Help Strategies Likely to Enhance Outcomes and Reduce Health Care CostsReferencesPCSS Mentoring ProgramPCSS Discussion ForumOpioid Response Network (STR-TA)Session Evaluation and CertificateUpcoming PCSS WebinarSlide Number 69